Halozyme Therapeutics
HALO
eBay
EBAY
Hutchmed (China)
HCM
Teradata Corp
TDC
Precision Drilling
PDS
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -96.94%174K | 1,868.75%566K | -116.13%-232K | 985.27%4.86M | -528.21%-2.23M | 1,565.72%5.69M | 96.70%-32K | 11.91%1.44M | -88.98%448K | -66.39%521K |
Net income from continuing operations | 68.90%-404K | 175.44%298K | -14.24%-706K | -98.05%-2.13M | 120.13%181K | -814.79%-1.3M | -5,542.86%-395K | -2,107.14%-618K | -166.13%-1.08M | -155.98%-899K |
Operating gains losses | --0 | ---- | ---- | --14K | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization | -4.82%731K | -8.82%703K | -4.72%727K | -3.52%2.96M | -13.32%657K | 4.35%768K | -0.77%771K | -4.15%763K | -6.92%3.07M | -8.23%758K |
Other non cash items | 0.00%7K | 0.00%8K | 0.00%7K | 108.60%30K | 101.60%8K | -93.40%7K | -87.69%8K | 135.00%7K | -364.39%-349K | -1,100.00%-500K |
Change In working capital | -104.89%-300K | 73.82%-194K | -145.26%-558K | 319.43%3.45M | -446.35%-3.18M | 633.89%6.13M | 61.76%-741K | 105.84%1.23M | -19.94%-1.57M | 194.24%917K |
-Change in receivables | -88.91%324K | 159.25%535K | -105.44%-120K | 17.27%1.53M | -339.09%-2.7M | 621.23%2.92M | 40.63%-903K | -27.27%2.21M | 182.00%1.3M | -696.12%-614K |
-Change in inventory | -193.80%-1.33M | 217.96%440K | 140.66%233K | 186.06%1.97M | -5.67%1.5M | 437.86%1.42M | 62.29%-373K | 76.77%-573K | -188.45%-2.29M | 1,017.34%1.59M |
-Change in prepaid assets | 50.00%-24K | 228.34%614K | -182.76%-246K | -113.17%-599K | -261.67%-651K | -1,700.00%-48K | 9,450.00%187K | 14.71%-87K | -11.07%-281K | -127.85%-180K |
-Change in payables and accrued expense | 253.12%1.5M | -215.52%-670K | 26.03%184K | -227.73%-1.45M | -236.36%-1.2M | -16.73%-977K | -21.52%580K | -58.76%146K | 171.27%1.14M | 364.26%880K |
-Change in other current liabilities | -13.33%-221K | -13.09%-216K | -12.90%-210K | -13.56%-779K | -13.74%-207K | -12.72%-195K | -14.37%-191K | -13.41%-186K | 2.14%-686K | -13.75%-182K |
-Change in other working capital | -118.08%-544K | -2,087.80%-897K | -46.15%-399K | 468.66%2.78M | 114.11%81K | 2,488.10%3.01M | -2,150.00%-41K | -396.36%-273K | -413.75%-753K | -73.41%-574K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -96.94%174K | 1,868.75%566K | -116.13%-232K | 985.27%4.86M | -528.21%-2.23M | 1,565.72%5.69M | 96.70%-32K | 11.91%1.44M | -88.98%448K | -66.39%521K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 44.42%-269K | -171.46%-1.11M | 88.59%-111K | 10.55%-2.11M | 35.70%-245K | 25.88%-484K | 54.29%-410K | -126.28%-973K | -73.09%-2.36M | 0.00%-381K |
Net PPE purchase and sale | 44.42%-269K | -171.46%-1.11M | 88.59%-111K | 10.55%-2.11M | 35.70%-245K | 25.88%-484K | 54.29%-410K | -126.28%-973K | -73.09%-2.36M | 0.00%-381K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 44.42%-269K | -171.46%-1.11M | 88.59%-111K | 10.55%-2.11M | 35.70%-245K | 25.88%-484K | 54.29%-410K | -126.28%-973K | -73.09%-2.36M | 0.00%-381K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 100.64%34K | 269.48%569K | -41.42%222K | -271.35%-2.69M | 4,182.35%2.08M | -1,849.17%-5.3M | -93.67%154K | 133.90%379K | 134.23%1.57M | 95.87%-51K |
Net issuance payments of debt | 100.64%34K | 269.48%569K | -41.42%222K | -267.61%-2.66M | 4,182.35%2.08M | -1,733.13%-5.28M | -93.67%154K | 133.90%379K | 134.67%1.59M | 95.87%-51K |
Net other financing activities | ---- | ---- | ---- | -25.00%-25K | --0 | ---- | ---- | ---- | ---20K | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 100.64%34K | 269.48%569K | -41.42%222K | -271.35%-2.69M | 4,182.35%2.08M | -1,849.17%-5.3M | -93.67%154K | 133.90%379K | 134.23%1.57M | 95.87%-51K |
Net cash flow | ||||||||||
Beginning cash position | -70.49%247K | -80.00%225K | 23.13%346K | -55.18%281K | 285.42%740K | -10.00%837K | 209.07%1.13M | -55.18%281K | -74.97%627K | -72.25%192K |
Current changes in cash | 37.11%-61K | 107.64%22K | -114.34%-121K | 118.79%65K | -542.70%-394K | 86.86%-97K | -150.88%-288K | 420.91%844K | 81.58%-346K | 236.92%89K |
End cash Position | -74.86%186K | -70.49%247K | -80.00%225K | 23.13%346K | 23.13%346K | 285.42%740K | -10.00%837K | 209.07%1.13M | -55.18%281K | -55.18%281K |
Free cash flow | -101.83%-95K | -25.34%-554K | -173.76%-343K | 243.39%2.74M | -1,873.57%-2.48M | 599.81%5.2M | 76.33%-442K | -45.61%465K | -170.85%-1.91M | -88.02%140K |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |